ABSI
Absci Corporation$5.14-0.41 (-7.31%)Prev Close$5.54·MCap$901.1M·P/E—·Vol2.85M·Yield—
▲
Buys (12M)
7
$1.22M
▼
Sells (12M)
11
$387.0K
◆
Net Activity
Net Buyer
$831.1K
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Absci Corporation (ABSI) has been dominated by buying, with 7 insider purchases totaling $1.22M and 11 insider sales totaling $387.0K. The most recent insider transaction was by Pangalos Menelas N (director), who purchased $200.7K worth of shares on May 13, 2026. Absci Corporation operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $901.1M.
ABSI Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 13, 2026 | Pangalos Menelas N | director | Buy | 37,453 | $5.36 | $200.7K | 232,308 |
| Mar 16, 2026 | Busch Andreas | officer: Chief Innovation Officer | Buy | 100,000 | $2.29 | $229.0K | 421,446+31% |
| Mar 3, 2026 | Pangalos Menelas N | director | Buy | 75,095 | $2.74 | $205.8K | 189,055+66% |
| Feb 3, 2026 | Busch Andreas | Chief Innovation Officer | Sell | 1,469 | $2.99 | $4.4K | 0 |
| Feb 2, 2026 | Bedrick Todd | SVP, CAO | Sell | 3,659 | $2.99 | $10.9K | 0 |
| Feb 2, 2026 | Jonasson Zachariah | CFO / CBO | Sell | 17,496 | $2.99 | $52.3K | 0 |
| Feb 2, 2026 | McClain Sean | Chief Executive Officer | Sell | 26,761 | $2.99 | $80.0K | 0 |
| Dec 5, 2025 | VAN HOUTEN FRANS | Director | Buy | 40,000 | $3.72 | $148.8K | 0 |
| Nov 30, 2025 | Jonasson Zachariah | CFO / CBO | Sell | 8,320 | $3.17 | $26.4K | 0 |
| Oct 14, 2025 | Bedrick Todd | SVP, CAO | Sell | 21,950 | $3.68 | $80.8K | 0 |
| Oct 14, 2025 | Busch Andreas | Chief Innovation Officer | Sell | 3,092 | $3.68 | $11.4K | 0 |
| Oct 14, 2025 | Jonasson Zachariah | CFO / CBO | Sell | 387 | $3.68 | $1.4K | 0 |
| Oct 14, 2025 | McClain Sean | Chief Executive Officer | Sell | 23,293 | $3.68 | $85.7K | 0 |
| Sep 22, 2025 | Bedrick Todd | SVP, CAO | Buy | 10,000 | $2.70 | $27.0K | 0 |
| Sep 22, 2025 | Pangalos Menelas N | Director | Buy | 95,785 | $2.66 | $254.8K | 0 |
| Aug 31, 2025 | Jonasson Zachariah | CFO / CBO | Sell | 8,319 | $2.39 | $19.9K | 0 |
| Jul 28, 2025 | Busch Andreas | Chief Innovation Officer | Buy | 50,000 | $3.04 | $152.0K | 0 |
| May 31, 2025 | Jonasson Zachariah | CFO / CBO | Sell | 5,194 | $2.65 | $13.8K | 0 |
| Feb 28, 2025 | Jonasson Zachariah | CFO / CBO | Sell | 5,219 | $4.04 | $21.1K | 0 |
| Jun 14, 2024 | Jonasson Zachariah | CFO / CBO | Sell | 19,859 | $4.98 | $98.9K | 384,751 |
| May 28, 2024 | Phoenix Venture Partners II LP | Sell | 3,100,000 | $4.40 | $13.64M2.0% OS | 11,279,522 | |
| Mar 5, 2024 | Redmile Group, LLC | Director | Buy | 222,222 | $4.50 | $1000.0K | 8,253,316 |
| Feb 10, 2022 | Korman Sarah | General Counsel | Buy | 4,250 | $7.96 | $33.8K | 14,250+43% |
| Jan 24, 2022 | Bedrick Todd | VP, CCPAO | Buy | 2,000 | $7.50 | $15.0K | 3,000+200% |
| Jan 19, 2022 | McClain Sean | President and Chief Executive | Buy | 7,155 | $6.92 | $49.5K | 6,368,955 |
| Jul 28, 2021 | Bedrick Todd | VP, CCPAO | Buy | 1,000 | $16.00 | $16.0K | 1,000 |
| Jul 28, 2021 | Casdin Partners Master Fund, L.P. | Director | Buy | 1,562,500 | $16.00 | $25.00M1.0% OS | 6,745,333+30% |
| Jul 28, 2021 | Jonasson Zachariah | Director | Buy | 9,000 | $16.00 | $144.0K | 9,000 |
| Jul 28, 2021 | Korman Sarah | General Counsel | Buy | 10,000 | $16.00 | $160.0K | 10,000 |
| Jul 28, 2021 | McClain Sean | President and Chief Executive | Buy | 600 | $16.00 | $9.6K | 6,361,800 |
| Jul 28, 2021 | MCGINNIS KAREN K | Director | Buy | 15,000 | $16.00 | $240.0K | 15,000 |
| Jul 28, 2021 | Redmile Group, LLC | Director | Buy | 1,875,000 | $16.00 | $30.00M1.2% OS | 8,031,094+30% |
ABSI Insider Buying Activity
The following table shows recent insider purchases of Absci Corporation (ABSI) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 13, 2026 | Pangalos Menelas N | director | Buy | 37,453 | $5.36 | $200.7K | 232,308 |
| Mar 16, 2026 | Busch Andreas | officer: Chief Innovation Officer | Buy | 100,000 | $2.29 | $229.0K | 421,446+31% |
| Mar 3, 2026 | Pangalos Menelas N | director | Buy | 75,095 | $2.74 | $205.8K | 189,055+66% |
| Dec 5, 2025 | VAN HOUTEN FRANS | Director | Buy | 40,000 | $3.72 | $148.8K | 0 |
| Sep 22, 2025 | Bedrick Todd | SVP, CAO | Buy | 10,000 | $2.70 | $27.0K | 0 |
| Sep 22, 2025 | Pangalos Menelas N | Director | Buy | 95,785 | $2.66 | $254.8K | 0 |
| Jul 28, 2025 | Busch Andreas | Chief Innovation Officer | Buy | 50,000 | $3.04 | $152.0K | 0 |
| Mar 5, 2024 | Redmile Group, LLC | Director | Buy | 222,222 | $4.50 | $1000.0K | 8,253,316 |
| Feb 10, 2022 | Korman Sarah | General Counsel | Buy | 4,250 | $7.96 | $33.8K | 14,250+43% |
| Jan 24, 2022 | Bedrick Todd | VP, CCPAO | Buy | 2,000 | $7.50 | $15.0K | 3,000+200% |
| Jan 19, 2022 | McClain Sean | President and Chief Executive | Buy | 7,155 | $6.92 | $49.5K | 6,368,955 |
| Jul 28, 2021 | Bedrick Todd | VP, CCPAO | Buy | 1,000 | $16.00 | $16.0K | 1,000 |
| Jul 28, 2021 | Casdin Partners Master Fund, L.P. | Director | Buy | 1,562,500 | $16.00 | $25.00M1.0% OS | 6,745,333+30% |
| Jul 28, 2021 | Jonasson Zachariah | Director | Buy | 9,000 | $16.00 | $144.0K | 9,000 |
| Jul 28, 2021 | Korman Sarah | General Counsel | Buy | 10,000 | $16.00 | $160.0K | 10,000 |
| Jul 28, 2021 | McClain Sean | President and Chief Executive | Buy | 600 | $16.00 | $9.6K | 6,361,800 |
| Jul 28, 2021 | MCGINNIS KAREN K | Director | Buy | 15,000 | $16.00 | $240.0K | 15,000 |
| Jul 28, 2021 | Redmile Group, LLC | Director | Buy | 1,875,000 | $16.00 | $30.00M1.2% OS | 8,031,094+30% |
ABSI Insider Selling Activity
The following table shows recent insider sales of Absci Corporation (ABSI) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | Busch Andreas | Chief Innovation Officer | Sell | 1,469 | $2.99 | $4.4K | 0 |
| Feb 2, 2026 | Bedrick Todd | SVP, CAO | Sell | 3,659 | $2.99 | $10.9K | 0 |
| Feb 2, 2026 | Jonasson Zachariah | CFO / CBO | Sell | 17,496 | $2.99 | $52.3K | 0 |
| Feb 2, 2026 | McClain Sean | Chief Executive Officer | Sell | 26,761 | $2.99 | $80.0K | 0 |
| Nov 30, 2025 | Jonasson Zachariah | CFO / CBO | Sell | 8,320 | $3.17 | $26.4K | 0 |
| Oct 14, 2025 | Bedrick Todd | SVP, CAO | Sell | 21,950 | $3.68 | $80.8K | 0 |
| Oct 14, 2025 | Busch Andreas | Chief Innovation Officer | Sell | 3,092 | $3.68 | $11.4K | 0 |
| Oct 14, 2025 | Jonasson Zachariah | CFO / CBO | Sell | 387 | $3.68 | $1.4K | 0 |
| Oct 14, 2025 | McClain Sean | Chief Executive Officer | Sell | 23,293 | $3.68 | $85.7K | 0 |
| Aug 31, 2025 | Jonasson Zachariah | CFO / CBO | Sell | 8,319 | $2.39 | $19.9K | 0 |
| May 31, 2025 | Jonasson Zachariah | CFO / CBO | Sell | 5,194 | $2.65 | $13.8K | 0 |
| Feb 28, 2025 | Jonasson Zachariah | CFO / CBO | Sell | 5,219 | $4.04 | $21.1K | 0 |
| Jun 14, 2024 | Jonasson Zachariah | CFO / CBO | Sell | 19,859 | $4.98 | $98.9K | 384,751 |
| May 28, 2024 | Phoenix Venture Partners II LP | Sell | 3,100,000 | $4.40 | $13.64M2.0% OS | 11,279,522 |
ABSI Insiders
Similar Stocks to ABSI
VRTX
Vertex Pharmaceuticals Incorporated
$436.80-3.02%
$114.32B
REGN
Regeneron Pharmaceuticals, Inc.
$699.83-1.87%
$73.44B
ALNY
Alnylam Pharmaceuticals, Inc.
$289.07-1.46%
$39.18B
RVMD
Revolution Medicines, Inc.
$145.16-2.80%
$31.78B
INSM
Insmed Incorporated
$109.78-5.14%
$25.06B
UTHR
United Therapeutics Corporation
$568.58-1.47%
$24.13B
ROIV
Roivant Sciences Ltd.
$29.29-0.08%
$20.96B
MRNA
Moderna, Inc.
$49.04-2.34%
$19.46B